FDA Variance Approval Letter to Anthony Ritzko
Summary
The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to Anthony Ritzko. The letter, dated March 24, 2025, is available in both redacted and unredacted forms.
What changed
The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to an individual named Anthony Ritzko. The letter, dated March 24, 2025, indicates a specific approval related to a variance. While the exact nature of the variance is not detailed due to redactions for personally identifiable information, it pertains to medical device regulations.
Compliance officers should note this as an individual approval rather than a broad regulatory change. The availability of both redacted and unredacted versions suggests that the core approval details are public, but specific identifying information is protected. No immediate actions are required for entities other than the named recipient, but it serves as an example of the FDA's variance approval process for medical devices.
Source document (simplified)
Content
There are no documents available to view or download
Attachments 2
Variance Approval Letter from FDA CDRH to Anthony Ritzko
Restricted: Personally Identifiable Information
More Information
- Author(s) CDRH
Variance Approval Letter from FDA CDRH to Anthony Ritzko_Redacted
More Information
- Author(s) CDRH
Download
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when Regs.gov: Food and Drug Administration publishes new changes.